They found the higher ZFAS1 expression were correlated with tumor thickness, lymph node metastasis, tumor stages in poor disease-free survival time (DFS) or over survival (OS) of melanoma patients. The gene discussed is ZFAS1; the disease is metastatic malignant neoplasm in the lymph nodes.